Clinical Trial Update: BEVERLY-C: An Observational Study of Avastin (Bevacizumab) in First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer

View source ↗

Summary

An observational study assessing first-line use of bevacizumab (Avastin) in elderly patients with metastatic colorectal cancer; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Status: COMPLETED